Search

everythinglearnresearchcommunity

for

Search:↓

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

Hair grays due to oxidative stress and fewer functioning melanocytes.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Autophagy is crucial for normal sebaceous gland function and sebum composition.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Lifestyle changes are the first step in treating infertility in PCOS, followed by medications like clomiphene and metformin, and then surgery if needed.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Organs like hair follicles can renew themselves in complex ways, adapting to different needs and environments.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Laser hair removal improves life quality short-term for women with PCOS-related hirsutism.

EH-MSCs may help treat hair loss by reducing inflammation.

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.